Efficacy and Safety of Voglibose Compared With Acarbose in Patients With Type 2 Diabetes Inadequately Controlled on Metformin Alone: a Randomized, Open-label, Non-inferiority Study
Phase of Trial: Phase IV
Latest Information Update: 08 Feb 2017
At a glance
- Drugs Voglibose (Primary) ; Acarbose; Metformin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Takeda
- 07 Jun 2017 Biomarkers information updated
- 14 Jul 2016 Status changed from recruiting to completed.
- 19 Jan 2016 Planned End Date changed from 1 Mar 2016 to 1 Apr 2016 as reported by ClinicalTrials.gov record.